BERNA: a century of immunobiological innovation.
Abstract: At the time the Swiss Serum and Vaccine Institute Berne (BERNA) was found in 1898, few vaccines or immune globulins were available. This short list included vaccines against cholera, typhoid fever, plague, smallpox and rabies and equine anti-tetanus and diphtheria immune globulins. Furthermore, their use was restricted due to limited production capacity, uncertainty regarding safety and no public health infrastructure to promote their utilization. Today, safe and effective vaccines exist for more than 30 infectious diseases while human hyperimmune globulins exist to treat or prevent rabies, tetanus, respiratory syncytial virus, cytomegalovirus, hepatitis A, hepatitis B, and herpes virus (Varicella zoster) infections. Throughout its 100 years of existence, BERNA has played a key role in the evolution of the field by introducing novel technology leading to safer, and more efficacious vaccines. It was a pioneer in the development of freeze dried smallpox vaccine free from bacterial contamination. The Salmonella typhi Ty21a typhoid fever vaccine strain demonstrated that oral immunization against enteric bacterial pathogens was not only feasible, but could be accomplished with a virtual lack of attendant adverse reactions. This finding has served as an impetus to develop other live attenuated bacterial strains not only as vaccines, but also as vectors for vaccine antigens and gene therapy. One such example is Vibrio cholerae CVD 103-HgR, the first live vaccine for human use derived through recombinant DNA technology. Subsequent studies have shown that these two vaccine strains can be combined without sacrificing safety or immunogenicity, setting the cornerstone for combined orally administered vaccines. Recently, a novel vaccine antigen delivery system, termed virosomes, has been utilized to construct hepatitis A and influenza vaccines. Such vaccines elicit fewer local adverse reactions than their classical counterparts and display enhanced immunogenicity. Virosome-formulated influenza vaccine has also been shown to be safe and immunogenic, when administered by the intranasal route.
Publication Date: 1999-10-03 PubMed ID: 10506402DOI: 10.1016/s0264-410x(99)00228-5Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study documents the history and advancements brought upon by the Swiss Serum Vaccine Institute Berne (BERNA) in the vaccine and immunobiological field over a century. The researchers highlight the evolution from few resources and uncertainty regarding safety to the availability of effective vaccines for over 30 diseases today, thanks to institutes like BERNA.
Background
- The Swiss Serum and Vaccine Institute Berne (BERNA) was established in 1898, a time when vaccines were limited in availability. Back then, vaccines only existed for cholera, typhoid fever, plague, smallpox and rabies. Additionally, there was a shortage of equine anti-tetanus and diphtheria immune globulins.
- The use of these early vaccines was limited due to restricted production capacities, safety uncertainties, and lack of public health infrastructure to promote their use.
Progression and Achievements
- The researchers explain that today, there are safe and effective vaccines for over 30 infectious diseases, thanks to institutes like BERNA. Human hyperimmune globulins are also available now to treat or prevent diseases like rabies, tetanus, respiratory syncytial virus, cytomegalovirus, hepatitis A and B, and herpes virus infections.
- BERNA has also introduced novel technology leading to safer and more efficacious vaccines. It led the way in developing a freeze-dried smallpox vaccine free from bacterial contamination. They also formulated the Salmonella typhi Ty21a typhoid fever vaccine strain, demonstrating that oral immunization against enteric bacterial pathogens was possible, with minimal side effects.
Advancements in Vaccine Development
- This development spurred on the development of other live attenuated bacterial strains, not just as vaccines but as vectors for vaccine antigens and gene therapy. For instance, Vibrio cholerae CVD 103-HgR was the first live vaccine for human use derived via recombinant DNA technology.
- Studies showed these two vaccine strains could be combined without compromising safety or immunogenicity, paving the way for combined orally-administered vaccines. This was a significant milestone in the field.
Recent Innovations
- A new vaccine antigen delivery system, virosomes, was recently used to construct hepatitis A and influenza vaccines. These virosome-formulated vaccines were reported to cause fewer local adverse reactions than their traditional counterparts and showed enhanced immunogenicity.
- In addition, it was discovered that the virosome-formulated influenza vaccine was both safe and effective when administered intranasally.
Cite This Article
APA
Cryz SJ.
(1999).
BERNA: a century of immunobiological innovation.
Vaccine, 17 Suppl 2, S1-S5.
https://doi.org/10.1016/s0264-410x(99)00228-5 Publication
Researcher Affiliations
- BERNA, Swiss Serum and Vaccine Institute Berne, Rehhagstrasse 79, CH-3018, Bern, Switzerland.
MeSH Terms
- Academies and Institutes
- Antibodies, Viral / biosynthesis
- Blood
- Humans
- Immunoglobulins
- Switzerland
- Vaccines
- Vaccines, Attenuated
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
